Cited by 346Ubiquitin and proteasome pathwaysBRCA gene mutations in cancerCancer-related Molecular Pathways

Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

Open access
Brzovic, Peter S., Keeffe, Jennifer R., Nishikawa, Hiroyuki, Miyamoto, Keiko, Fox, David, Fukuda, Mamoru, Ohta, Tomohiko, Klevit, Rachel·2003·Proceedings of the National Academy of Sciences

Abstract

BRCA1 is a breast and ovarian cancer tumor suppressor protein that associates with BARD1 to form a RINGRING heterodimer. The BRCA1BARD1 RING complex functions as an ubiquitin (Ub) ligase with activity substantially greater than individual BRCA1 or BARD1 subunits. By using NMR spectroscopy and site-directed mutagenesis, we have mapped the binding site on the BRCA1BARD1 heterodimer for the Ub-conjugating enzyme UbcH5c. The results demonstrate that UbcH5c binds only to the BRCA1 RING domain and not the BARD1 RING. The binding interface is formed by the first and second Zn(2+)-loops and central alpha-helix of the BRCA1 RING domain, a region disrupted by cancer-predisposing mutations. Unexpectedly, a second Ub-conjugating enzyme, UbcH7, also interacts with the BRCA1BARD1 complex with similar affinity, although it is not active in Ub-ligase activity assays. Thus, binding alone is not sufficient for BRCA1-dependent Ub-ligase activity.

Integrity signals

Registry

Crossref · 10.1073/pnas.0836054100

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Brca1-Bard1 heterodimer, E2 binds only to the Brca1 RING, at residues proximal to but not within the dimerization interface.

    “In the context of the Brca1–Bard1 heterodimer, E2 binds only to the Brca1 RING, at residues proximal to (but not within) the dimerization interface [19].”

    From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [19]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., Fukuda, M., Ohta, T., & Klevit, R.
Affiliations
  • Department of Biochemistry, University of Washington, Seattle, WA 98195; and Division of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan
  • St. Marianna University School of Medicine (JP)
Venue
Proceedings of the National Academy of Sciences
Published
2003-05-05
Volume
100
Issue
10
Pages
5646-5651
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1969807455
Cited by
346
References
41
Citations by year
2026: 5 · 2025: 8 · 2024: 9 · 2023: 15 · 2022: 9 · 2021: 19 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 14 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 15 · 2012: 24
FWCI
6.29
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy
  • Battelle
  • Japan Society for the Promotion of Science
  • National Cancer Institute (R01CA079953, CA79953)
  • Biological and Environmental Research
  • Pacific Northwest National Laboratory
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
BRCA1, BARD1, ubiquitin ligase, UbcH5c, UbcH7, E3 ubiquitin ligase, protein-protein binding, RING domain, tumor suppressor, ubiquitination
MeSH terms
Amino Acid Sequence, Binding Sites, Carrier Proteins, Cloning, Molecular, Humans, Kinetics, Ligases, Models, Molecular, Neoplasms, Magnetic Resonance Spectroscopy, Protein Conformation, Recombinant Proteins, Mutagenesis, Site-Directed, Zinc Fingers, Sequence Alignment, Sequence Homology, Amino Acid, Protein Structure, Secondary, Dimerization, BRCA1 Protein, Genes, BRCA1, Protein Subunits, Tumor Suppressor Proteins, Ubiquitin, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review